Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
William R. Keller
Observed names:
W. Keller,
William Keller,
William R Keller
Institution:
Dartmouth College
Observed institutions:
Dartmouth College,
University of Maryland, Baltimore,
Dartmouth–Hitchcock Medical Center,
VA Capitol Health Care Network,
Mental Illness Research, Education and Clinical Centers
ORCID:
0000-0001-6580-1384
Observed ORCID:
0000-0001-6580-1384
OpenAlex ID:
A5070713968
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
2009
·
R. W. Buchanan
, J. Kreyenbuhl
, et al.
·
Schizophrenia Bulletin
·
901
Deconstructing negative symptoms of schizophrenia: Avolition–apathy and diminished expression clusters predict clinical presentation and functional outcome
2013
·
Gregory P. Strauss
, William P. Horan
, et al.
·
Journal of Psychiatric Research
·
431
Factor structure of the brief negative symptom scale
2012
·
Gregory P. Strauss
, L. Elliot Hong
, et al.
·
Schizophrenia Research
·
197
Next-generation negative symptom assessment for clinical trials: Validation of the Brief Negative Symptom Scale
2012
·
Gregory P. Strauss
, William R. Keller
, et al.
·
Schizophrenia Research
·
190
A review of anti-inflammatory agents for symptoms of schizophrenia
2012
·
William R Keller
, Lionel M Kum
, et al.
·
Journal of Psychopharmacology
·
108
Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms
2015
·
Deanna L. Kelly
, Kelli M. Sullivan
, et al.
·
Journal of Clinical Psychopharmacology
·
103
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
2012
·
Robert W. Buchanan
, Julie Kreyenbuhl
, et al.
·
FOCUS The Journal of Lifelong Learning in Psychiatry
·
84
Cortical structural abnormalities in deficit versus nondeficit schizophrenia
2012
·
Bernard A. Fischer
, William R. Keller
, et al.
·
Schizophrenia Research
·
59
Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia
2015
·
Gregory P. Strauss
, William R. Keller
, et al.
·
Schizophrenia Research
·
54
Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia
2015
·
Gregory P. Strauss
, William R. Keller
, et al.
·
Schizophrenia Research
·
51
Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia
2019
·
Gregory P. Strauss
, Hannah C. Chapman
, et al.
·
Journal of Psychiatric Research
·
48
Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia
2015
·
Gregory P. Strauss
, William R. Keller
, et al.
·
Schizophrenia Research
·
46
Revisiting the Diagnosis of Schizophrenia: Where have we been and Where are We Going?
2010
·
William R. Keller
, Bernard A. Fischer
, et al.
·
CNS Neuroscience & Therapeutics
·
46
PDF
Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
2013
·
Deanna L Kelly
, Heidi J Wehring
, et al.
·
BMC Psychiatry
·
45
PDF
Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia
2014
·
Robert W. Buchanan
, Elaine Weiner
, et al.
·
Schizophrenia Bulletin
·
24
Hyperdeactivation of the Default Mode Network in People With Schizophrenia When Focusing Attention in Space
2016
·
Britta Hahn
, Alexander N. Harvey
, et al.
·
Schizophrenia Bulletin
·
21
PDF
Anhedonia reflects impairment in making relative value judgments between positive and neutral stimuli in schizophrenia
2018
·
Gregory P. Strauss
, Katherine Frost Visser
, et al.
·
Schizophrenia Research
·
14
C-14 * Plasma Oxytocin Levels are Associated with Impaired Social Cognition and Neurocognition in Schizophrenia
2014
·
K. Frost
, W. Keller
, et al.
·
Archives of Clinical Neuropsychology
·
14
Endogenous oxytocin levels are associated with facial emotion recognition accuracy but not gaze behavior in individuals with schizophrenia
2022
·
Michael J. Spilka
, William R. Keller
, et al.
·
Acta Psychiatrica Scandinavica
·
13
PDF
Community Adherence to Schizophrenia Treatment and Safety Monitoring Guidelines
2013
·
William R. Keller
, Bernard A. Fischer
, et al.
·
The Journal of Nervous and Mental Disease
·
12
The Recognition and Management of Early Psychosis
2010
·
William R. Keller
·
The Journal of Nervous and Mental Disease
·
7
The Risk of Diabetes in Deficit Schizophrenia
2013
·
William R. Keller
, Carol Vidal
, et al.
·
Clinical Schizophrenia & Related Psychoses
·
4
Open-label salsalate for the treatment of pre-diabetes in people with schizophrenia
2013
·
William R. Keller
, Bernard A. Fischer
, et al.
·
Schizophrenia Research
·
3
Aberrant visual attention is associated with social judgements of attractiveness and negative symptoms in schizophrenia
2025
·
Lauren Luther
, Rebecca F. Mathis
, et al.
·
Schizophrenia Research
·
2
The 2009 schizophrenia patient outcomes research team (PORT) psychopharmacological treatment recommendations
2011
·
Julie Kreyenbuhl
, Robert Buchanan
, et al.
·
International Clinical Psychopharmacology
·
2
Show more works
View as search
Works count:
28
Citation count:
2,480
H-index:
16
I10-index:
20
Year
Topic
Type
